Skip to content
healthcare.dev

AMLODIPINE BESYLATE

NDC 70518-0835, AMLODIPINE BESYLATE, tablet, from REMEDYREPACK INC..

Product NDC
70518-0835
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0835 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE5 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
70518-0835-37051808350330 TABLET in 1 BLISTER PACK (70518-0835-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d09173a1-5e3c-4c86-8c7c-15238925ef50

Use it

Look up 70518-0835 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0835 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-0835. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.